Delayed wound healing in immunodeficient TGF-β1 knockout mice

Journal of Investigative Dermatology

Volumn 115, Issue 1, 2000, Pages 3-11

  Crowe, Maria J ^a,b   Doetschman, Thomas ^a   Greenhalgh, David G ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene expression; Knockout mice; Skin injury; Transforming growth factor isoforms

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE DEFICIENCY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; WOUND HEALING IMPAIRMENT;

EID: 0033926275     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00010.x     Document Type: Article

References (53)

1. Adams DH, Hathaway DM, Shaw J, Bumett D, Elias E, Strain AJ: Transforming growth factor-β induces T lymphocyte migration in vitro. J Immunol 147:609-612, 1991
2. Beck LS, Deguzman L, Lee WP, Xu Y, McFatride L, Amento EP: TGF-β1 accelerates wound healing: reversal of steroid-impaired healing in rats and rabbits. Growth Factors 5:295-304, 1991
3. Brown DL, Kao WW-Y, Greenhalgh DG: Apoptosis down-regulates inflammation under the advancing epithelial wound edge: Delayed patterns in diabetes and improvement with topical growth factors. Surgery 121:372-380, 1997
4. Brown RL, Ormsby I, Doetschman TC, Greenhalgh DG: Wound healing in the transforming growth factor-β1-deficient mouse. Wound Rep Reg 3:25-36, 1995
5. Buja LM, Eigenbrodt ML, Eigenbrodt EH: Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 117:1208-1214, 1993
6. Clark RAF. Wound repair - overview and general considerations. In: Dark RAF (ed.). The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1996, pp 3-50
7. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66, 1996
8. Diebold RJ, Eis MJ, Yin M, et al: Early-onset multifocal inflammation in the transforming growth factor-β1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 92:12215-12219, 1995
9. Doetschman T: Interpretation of phenotype in genetically engineered mice. Laboratory Anim Sci 49:137-143, 1999
10. Greenhalgh DG, Staley MJ. Burn wound healing. In: Richard RL, Staley MJ (eds). Burn Care and Rehabilitation: Principles and Practice. Philadelphia, PA: FA Davis Co., 1993, pp 70-102
11. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R: PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136:1235-1246, 1990
12. Heine UI, Munoz EF, Flanders KC, et al: Role of the transforming growth factor-beta in the development of the mouse embryo. J Cell Biol 105:2861-2876, 1987
13. Hosgood G: Wound healing - Role of platelet-derived growth factor and transforming growth factor-beta. [Review] Vet Surg 22:490-495, 1993
14. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J: Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nature Genet 11:415-421, 1995
15. Kallapur S, Ormsby I, Doetschman T: Strain dependency of TGF-β1 function during embryogenesis. Mol Reprod Dev 52:341-349, 1999
16. Kelso A, Glasebrook AL, Kanagawa O, Brunner KT: Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. J Immunol 129:550-556, 1982
17. Knisely TL, Bleicher PA, Vibbard CA, Granstein RD: Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells. Curr Eye Res 10:761-771, 1991
18. Kulkarni AB, Hub CG, Becker B, et al: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774, 1993
19. Kupper TS, Green DR: Immunoregulation after thermal injury: sequential appearance of 1-J+, Ly-I T suppressor inducer cells and Ly-2 T suppressor effector cells following thermal trauma in mice. J Immunol 135:3053-3050, 1984
20. Kyprianou N, Isaacs JT: Expression of transforming growth factor-β in the rat ventral prostate programmed cell death. Mol Endocrinol 89:1515-1522, 1989
21. Lanning DA, Diegelmann RF, Yager DR, Wallace ML, Bagwell CE, Haynes JH: Myofibroblast induction with transforming growth factor-betal and -beta3 in cutaneous fetal excisional wounds. J Pediatr Surg 35:183-187, 2000
22. Lehnert SA, Akhurst RJ: Embryonic expression pattern of TGF-beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 104:263-272, 1988
23. Letterio JJ, Roberts AB: Transforming growth factor-β1-deficient mice: identification of isoform-specific activities in vivo. J Leukoc Biol 59:769-774, 1996
24. Massagué J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990
25. Moss MM, Gough DB, Jordan AL: Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model. Surgery 104:882-887, 1988
26. Munster AM: Post-traumatic immunosuppression is due to activation of suppressor T cells. Lancet i:1329-1330, 1976
27. Nall AV, Brownlee RE, Colvin CP, et al: Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol 122:171-177, 1996
28. Oberhammer FA, Pavelka M, Sharms S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor 131. Proc Natl Acad Sci USA 89:5408-5412, 1992
29. Parekh T, Saxena B, Reibman J, Cronstein BN, Gold LI: Neutrophil chemotaxis in response to TGF-β isoforms (TGF-β1, TGF-β2, and TGF-β3). J Immunol 152:2456-2466, 1994
30. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH: Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 165:251-256, 1987
31. Proetzel G, Pawlowski S, Yin M, et al: Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet 11:409-414, 1995
32. Querfeld C, Eckes B, Huerkamp C, Krieg T, Sollberg S: Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci 21:13-22, 1999
33. Rehman JA, LeBien TW: Transforming growth factor-β regulates normal human pre-B cell differentiation. Int Immunol 6:315-322, 1993
34. Roberts AB, Sporn MB. The transforming growth factors-β. In: Sporn MB, Roberts AB (eds). Peptide Growth Factors and Their Receptors. Berlin: Springer-Verlag, 1990, pp 419-472
35. Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986
36. Roberts AB, Flanders KC, Kondaiah P, et al: Transforming growth factor P. biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Horm Res 44:157-197, 1988
37. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al: TGFβ2 knockout mice have multiple developmental defects that are non overlapping with other TGFβ knockout phenotypes. Dev 124:2659-2670, 1997
38. Schwartzman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133-151, 1993
39. Shah M, Foreman DM, Ferguson MWJ: Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107:1137-1157, 1994
40. 3, to cutaneous rat wounds reduces scarring. J Cell Sci 108:985-1002, 1995
41. Shull MM, Ormsby I, Kier A, et al: Targeted disruption of the murine TGFβ1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
42. Shull MM, Kier A, Diebold RJ, Yin M-Y, Doetschman T. The importance of transforming growth factor β1 in immunological homeostasis as revealed by gene ablation in mice. In: Jacob C (ed.) Overexpression and Knockout of Cytokine in Transgenic Mice. London: Academic Press, 1994, pp 135-159
43. Smeland EB, Blomhoff HK, Holte H, et al: Transforming growth factor beta (TGF-β) inhibits Gl to S transition, but not activation of human B lymphocytes. Exp Cell Res 171:213-222, 1987
44. Stewart BW: Mechanisms of apoptosis: Integration of genetic, biochemical and cellular indicators. J Natl Cancer Inst 86:1286-1296, 1994
45. Ueda N, Shah SV: Apoptosis. J Lab Clin Med 124:169-177, 1994
46. Wahl SM: Transforming growth factor beta (TGF-β) in inflammation; a cause and a cure. J Clin Immunol 12:61-74, 1992
47. Wahl SM: Transforming growth factor β: the good, the bad, and the ugly. J Exp Med 180:1587-1590, 1994
48. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB: Transforming growth factor-β induces monocyte chemotaxis and growth factor production. Proc Natl Acadsci USA 84:5788-5792, 1987
49. Wang X, Smith P, Pu LL, Kirn YJ, Ko F, Robson MC: Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 87:194-200, 1999
50. Williams GT, Smith CA: Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74:777-779, 1993
51. Yanagihara K, Tsumuraya M: Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 52:4042-4045, 1992
52. Yang L, Qiu CX, Ludlow A, Ferguson MW, Brunner G: Active transforming growth factor-beta in wound repair: determination using a new assay. Am J Pathol 154:105-111, 1999
53. Yonish-Rouach E, Grunwald D, Wilder S, Kirnchi A, May E, Lawrence J-J, May P, Oren M: p53-Mediated cell death: relationship to cell cycle control. Mol Cell Biol 13:1415-1423, 1993